Lv4
490 积分 2024-04-10 加入
Enhancement of anti‐tumor immunity through local modulation of CTLA‐4 and GITR by dendritic cells
4小时前
已完结
Safety, Tolerability, and Potential Clinical Activity of a Glucocorticoid-Induced TNF Receptor-Related Protein Agonist Alone or in Combination With Nivolumab for Patients With Advanced Solid Tumors: A Phase 1/2a Dose-Escalation and Cohort-Expansion Clinical Trial
4小时前
已完结
Dose escalation results from a first-in-human, phase 1 study of glucocorticoid-induced TNF receptor–related protein agonist AMG 228 in patients with advanced solid tumors
4小时前
已完结
First‐in‐human phase 1 study of MK‐1248, an anti–glucocorticoid‐induced tumor necrosis factor receptor agonist monoclonal antibody, as monotherapy or with pembrolizumab in patients with advanced solid tumors
4小时前
已完结
Phase I Study of MK-4166, an Anti-human Glucocorticoid-Induced TNF Receptor Antibody, Alone or with Pembrolizumab in Advanced Solid Tumors
4小时前
已完结
Activation of regulatory T cells instigates functional down-regulation of cytotoxic T lymphocytes in human breast cancer
4小时前
已完结
First-in-human phase I/Ib open-label dose-escalation study of GWN323 (anti-GITR) as a single agent and in combination with spartalizumab (anti-PD-1) in patients with advanced solid tumors and lymphomas
4小时前
已完结
Experimental Medicine Study to Measure Immune Checkpoint Receptors PD‐1 and GITR Turnover Rates In Vivo in Humans
4小时前
已完结
Enhancement of anti‐tumor immunity through local modulation of CTLA‐4 and GITR by dendritic cells
4小时前
已完结
Safety and Clinical Activity of MEDI1873, a Novel GITR Agonist, in Advanced Solid Tumors
4小时前
已完结
Low-dose metformin targets the lysosomal AMPK pathway through PEN2
皖公网安备34019202002308
